Drug intelligence / Profile preview

AnQin

Development stage: Preclinical
Lead developer: Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Modality: Small Molecules
Administration: Otic, Topical

Overview

AnQin is a drug developed as a spray for the treatment of otitis externa mycotica, a fungal infection affecting the outer ear canal. It is administered topically into the ears. Clinical studies are underway to evaluate its effect on the microenvironment of the affected ear.

Other names: Anqin spray桉芩喷剂

Beyond the preview

Go deeper on AnQin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AnQin.

Explore the full profile